Daiwa Securities Group
GOSS icon

Daiwa Securities Group’s Gossamer Bio GOSS Stock Holding History

Daiwa Securities Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-771
Closed -$2K – 1286
2025
Q4 		$2K Buy
+771
New +$2.2K ﹤0.01% 1309
2023
Q4 		– Sell
-260
Closed – – 1349
2023
Q3 		$0 Hold
260
– – ﹤0.01% 1307
2023
Q2 		$0 Hold
260
– – ﹤0.01% 1332
2023
Q1 		$0 Hold
260
– – ﹤0.01% 1308
2022
Q4 		$1K Hold
260
– – ﹤0.01% 1271
2022
Q3 		$3K Hold
260
– – ﹤0.01% 1194
2022
Q2 		$2K Hold
260
– – ﹤0.01% 1237
2022
Q1 		$2K Hold
260
– – ﹤0.01% 1250
2021
Q4 		$3K Hold
260
– – ﹤0.01% 1241
2021
Q3 		$3K Buy
260
+117
+82% +$1.08K ﹤0.01% 1211
2021
Q2 		$1K Hold
143
– – ﹤0.01% 1193
2021
Q1 		$1K Hold
143
– – ﹤0.01% 1199
2020
Q4 		$1K Sell
143
-289
-67% -$2.85K ﹤0.01% 1178
2020
Q3 		$5K Buy
432
+59
+16% +$782 ﹤0.01% 1092
2020
Q2 		$4K Hold
373
– – ﹤0.01% 1120
2020
Q1 		$4K Hold
373
– – ﹤0.01% 1115
2019
Q4 		$6K Buy
+373
New +$7.51K ﹤0.01% 1093

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Daiwa Securities Group's GOSS Position: Q1 2026 in Review

Daiwa Securities Group sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 771 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in GOSS in Q4 2019 and held it in 17 quarters. The position peaked at $6K in Q4 2019. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Daiwa Securities Group reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 771 Gossamer Bio shares in Q1 2026, an estimated $2K.
  • Daiwa Securities Group first reported a position in Gossamer Bio in Q4 2019 and held it in 17 quarters.
  • Daiwa Securities Group's Gossamer Bio position peaked at $6K in Q4 2019.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.